Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT.
By S. Strickberger, J. Hummel, T. Bartlett, Howard I. Frumin, C. Schuger, S. Beau, Cynthia Bitar, F. Morady. Journal of the American College of Cardiology, 2003
604 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine
View Paper: https://www.semanticscholar.org/paper/c33b178c44778857fbc63c3de7a04975b771ad7a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- Bernard R. Chaitman
- Rick A. Nishimura
- J. Halperin
- Jose Luis Zamorano
- M. Creager
- Douglas P. Zipes
- C. Yancy
Citations in the corpus
- ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (2006, background): “ICD therapy did not improve the survival of patients with HF due to nonischemic DCM in 2 small trials.(635,645) However, the SCD-HeFT trial demonstrated a 23% reduction in total mortality with ICD treatment in comparison to placebo.”
- ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. (2008, background): “Another inconclusive trial was the AMIOVIRT (Amiodarone Versus Implantable Defibrillator in Patients with Nonischemic Cardiomyopathy and Asymptomatic Nonsustained Ventricular Tachycardia) study (378).”